Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Bristol-Myers Squibb (BMY.US)$ FDA Approves Augtyro (repotr...

$Bristol-Myers Squibb(BMY.US)$
FDA Approves Augtyro (repotrectinib) 🎉

⇨ next-gen. Tyrosine Kinase Inhibitor (TKI) ⚛️
⇨ the only FDA-approved treatment for NTRK-positive tumors 👏
⇨ accelerated approval (sNDA) marks its 2nd indication in the US

⇨ based on Ph1/2 TRIDENT-1 trial 🧫
» effective in both TKI-naïve & TKI-pretreated patients across solid tumors
» showed significant response rates
$Bristol-Myers Squibb (BMY.US)$ FDA Approves Augtyro (repotrectinib) 🎉  ⇨ next-gen. Tyrosine Kinase Inhibitor (TKI) ⚛️ ⇨ the only FDA-approved treatment for NT...
$Bristol-Myers Squibb (BMY.US)$ FDA Approves Augtyro (repotrectinib) 🎉  ⇨ next-gen. Tyrosine Kinase Inhibitor (TKI) ⚛️ ⇨ the only FDA-approved treatment for NT...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
1
+0
Translate
Report
24K Views
Comment
Sign in to post a comment
    挣钱养猫猫😺
    1959Followers
    23Following
    16KVisitors
    Follow